Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival

Molecular and Cellular Biology

Volumn 19, Issue 7, 1999, Pages 5073-5082

  Fujio, Yasushi ^a   Guo, Kun ^a,b   Mano, Toshiaki ^a   Mitsuuchi, Yasuhiro ^c   Testa, Joseph R ^c   Walsh, Kenneth ^a,d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SANOFI   (France)

^c FOX CHASE CANCER CENTER   (United States)

^d ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLIN DEPENDENT KINASE INHIBITOR; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; MUSCLE CELL; MYOBLAST; MYOTUBE; PRIORITY JOURNAL; PROTO ONCOGENE;

ADENOVIRIDAE;

EID: 0033001501     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.7.5073     Document Type: Article

References (60)

1. Alessi, D. R., M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and B. A. Hemmings. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:6541-6551.
2. Altomare, D. A., K. Guo, J. Q. Cheng, G. Sonoda, K. Walsh, and J. R. Testa. 1995. Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene. Oncogene 11:1055-1060.
3. Altomare, D. A., G. E. Lyons, Y. Mitsuuchi, J. Q. Cheng, and J. R. Testa. 1998. Akt2 mRNA is highly expressed in embryonic brown fat and AKT2 kinase is activated by insulin. Oncogene 16:2407-2411.
4. Andrés, V., and K. Walsh. 1996. Myogenin expression, cell cycle withdrawal and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132:657-666.
5. Bellacosa, A., T. F. Franke, M. E. Gonzalez-Portal, K. Datta, T. Taguchi, J. Gardner, J. Q. Cheng, J. R. Testa, and P. N. Tsichlis. 1993. Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications. Oncogene 8:745-754.
6. Bennett, A. M., and N. K. Tonks. 1997. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278:1288-1291.
7. Bett, A. J., W. Haddara, L. Prevec, and F. L. Graham. 1994. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91:8802-8806.
8. Cardone, M. H., N. Roy, H. R. Stennicke, G. S. Salvesen, T. F. Franke, E. Stanbridge, S. Frisch, and J. C Reed. 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318-1321.
9. Chen, D., K. Krasinski, D. Chen, A. Sylvester, J. Chen, P. D. Nisen, and V. Andrés. 1997. Down-regulation of cyclin-dependent kinase activity and cyclin A promoter activity in vascular smooth muscle cells by p27 (KIP-1), an inhibitor of neointima formation in the rat carotid artery. J. Clin. Investig. 99:2334-2341.
10. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
11. Coffer, P. J., J. Jin, and J. R. Woodgett. 1998. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335:1-13.
12. Datta, K., A. Bellacosa, T. O. Chan, and P. N. Tsichlis. 1996. Akt is a direct target of the phosphatidylinositol 3-kinase. J. Biol. Chem. 271:30835-30839.
13. Datta, S. R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M. E. Greenberg. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241.
14. Dominov, J. A., J. J. Dunn, and J. B. Miller. 1998. Bcl-2 expression identifies an early stage of myogenesis and promotes clonal expansion of muscle cells. J. Cell Biol. 142:537-544.
15. Dudek, H., S. R. Datta, T. F. Franke, M. J. Birnbaum, R. Yao, G. M. Cooper, R. A. Segal, D. R. Kaplan, and M. E. Greenberg. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-665.
16. Florini, J. R., E. Z. Ewton, and K. A. Magri. 1991. Hormones, growth factors and myogenic differentiation. Annu. Rev. Physiol. 53:201-216.
17. Florini, J. R., K. A. Magri, D. Z. Ewton, P. L. James, K. Grindstaff, and P. S. Rotwein. 1991. "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J. Biol. Chem. 266:15917-15923.
18. Franke, T. F., D. R. Kaplan, and L. C. Cantley. 1997. PI3K: downstream AKTion blocks apoptosis. Cell 88:435-437.
19. Franke, T. F., D. R. Kaplan, L. C. Cantley, and A. Toker. 1997. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-biphosphate. Science 275:665-668.
20. Franke, T. F., S.-I. Yang, T. O. Chan, K. Datta, A. Kazlauskas, D. K. Morrison, D. R. Kaplan, and P. N. Tsichlis. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phophatidylinositol 3-kinase. Cell 81:727-736.
21. Glücksmann, A. 1951. Cell deaths in normal vertebrate ontogeny. Biol. Rev. Cambridge Philos. Soc. 26:59-86.
22. Guo, K., and K. Walsh. 1997. Inhibition of myogenesis by multiple cyclin/cdk complexes: coordinate regulation of myogenesis and cell cycle activity at the level of E2F. J. Biol. Chem. 272:791-797.
23. Guo, K., J. Wang, V. Andrés, R. C. Smith, and K. Walsh. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15:3823-3829.
24. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021.
25. Hemmings, B. A. 1997. Akt signaling: linking membrane events to life and death decisions. Science 275:628-630.
26. Kipl. J. Clin. Investig. 103:597-604.
27. Hsieh, J.-K., F. S. G. Chan, D. J. O'Connor, S. Mittnacht, S. Zhong, and X. Lu. 1999. RB regulates the stability and the apoptotic function of p53 via MDM2. Mol. Cell 3:181-193.
28. Jiang, B.-H., M. Aoki, J. Z. Zheng, J. Li, and P. K. Vogt. 1999. Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. Proc. Natl. Acad. Sci. USA 96:2077-2081.
29. King, K. L., and J. A. Cidlowski. 1998. Cell cycle regulation and apoptosis. Annu. Rev. Physiol. 60:601-617.
30. King, W. G., M. D. Mattaliano, T. O. Chan, P. N. Tsichlis, and J. S. Brugge. 1997. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol. Cell. Biol. 17:4406-4418.
31. Kirshenbaum, L. A., M. Abdellatif, S. Chakraborty, and M. D. Schneider. 1996. Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription. Dev. Biol. 179:402-411.
32. Kitzmann, M., M. Vandromme, V. Schaeffer, G. Carnac, J.-C. Labbé, N. Lamb, and A. Fernandez. 1999. cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity. Mol. Cell. Biol. 19:3167-3176.
33. Klippel, A., W. M. Kavanaugh, D. Pot, and L. T. Williams. 1997. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol. Cell. Biol. 17:338-344.
34. Kohn, A. D., F. Takeuchi, and R. A. Roth. 1996. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J. Biol. Chem. 271:21920-21926.
35. Kou, K., and P. S. Rotwein. 1993. Transcriptional activation of the insulin-like growth factor-II gene during myoblast differentiation. Mol. Endocrinol. 7:291-302.
36. Kranenburg, O., A. J. van der Eb, and A. Zantema. 1996. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J. 15:46-54.
37. Kulik, G., and M. J. Weber. 1998. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor 1. Mol. Cell. Biol. 18:6711-6718.
38. Lindon, C., D. Montarras, and C. Pinset. 1998. Cell cycle-regulated expression of the muscle determination factor Myf5 in proliferating myoblasts. J. Cell Biol. 140:111-118.
39. Liu, Y., and R. N. Kitsis. 1996. Induction of DNA synthesis and apoptosis in cardiac myocytes by E1A oncoprotein. J. Cell Biol. 133:325-334.
40. Missero, C., E. Calautti, R. Eckner, J. Chin, L. H. Tsai, D. M. Livingston, and G. P. Dotto. 1995. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 chain protein in terminal differentiation. Proc. Natl. Acad. Sci. USA 92:5451-5455.
41. 2 phases of the cell cycle. J. Cell Biol. 135:441-456.
42. cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
43. Peso, L., M. Gonzalez-Garcia, C. Page, R. Herrera, and G. Nunez. 1997. Interleukin3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687-689.
44. WAF1 is required for survival of diferentiating neuroblastoma cells. Mol. Cell. Biol. 16:1335-1341.
45. Rosen, K. M., B. M. Wentworth, N. Rosenthal, and L. Villa-Komaroff. 1993. Specific, temporally regulated expression of the insulin-like growth factor II gene during muscle cell differentiation. Endocrinology 133:474-481.
46. Schneider, J. W., W. Gu, L. Zhu, V. Mahdavi, and B. Nadal-Ginard. 1994. Reversal of terminal differentiation mediated by p107 in Rb-/-muscle cells. Science 264:1467-1471.
47. Seemüller, E., A. Lupas, D. Stock, J. Löwe, R. Huber, and W. Baumeister. 1995. Proteasome from Thermoplasma acidophilum: a threonine protease. Science 268:579-582.
48. Sellers, W. R., B. G. Novitch, S. Miyake, A. Heith, G. A. Otterson, F. J. Kaye, A. B. Lassar, and W. G. Kaelin, Jr. 1998. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev. 12:95-106.
49. CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 11:1674-1689.
50. Song, A., Q. Wang, M. G. Goeble, and M. A. Harrington. 1998. Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol. Cell. Biol. 18:4994-4999.
51. Stewart, C. E. H., and P. Rotwein. 1996. Insulin-like growth factor-II is an automne survival factor for differentiating myoblasts. J. Biol. Chem. 271: 11330-11338.
52. Stokoe, D., L. R. Stephens, T. Copeland, P. R. J. Gaffney, C. B. Reese, G. F. Painter, A. B. Holmes, F. McCormick, and P. T. Hawkins. 1997. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277:567-570.
53. Testa, J. R., and A. Bellacosa. 1997. Membrane translocation and activation of the Akt kinase in growth factor-stimulated hematopoietic cells. Leuk. Res. 21:1027-1031.
54. Tollefsen, S. E., J. L. Sadow, and P. Rotwein. 1989. Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation. Proc. Natl. Acad. Sci. USA 86:1543-1547.
55. Walsh, K., and H. Perlman. 1997. Cell cycle exit upon myogenic differentiation. Curr. Opin. Genet. Dev. 7:597-602.
56. Wang, J., K. Guo, K. N. Wills, and K. Walsh. 1997. Rb functions to inhibit apoptosis during myocyte differentiation. Cancer Res. 57:351-354.
57. Wang, J., and K. Walsh. 1996. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273:359-361.
58. Yoshida, S., A. Fujisawa-Sehara, T. Taki, K. Arai, and Y. Nabeshima. 1996. Lysophosphatidic acid and bFGF control different modes in proliferating myoblasts. J. Cell Biol. 132:181-193.
59. Zacksenhaus, E., Z. Jiang, D. Chung, J. D. Marth, R. A. Phillips, and B. L. Gallie. 1996. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10:3051-3064.
60. KIP2 control muscle differentiation at the myogenin step. Genes Dev. 13:213-224.